Age at enrollment, yrs | 1.02 (1.00 to 1.03)† | 1.02 (1.00 to 1.03)† | 1.02 (1.01 to 1.03)† | 1.02 (1.00 to 1.03)† | 1.02 (1.00 to 1.03)† |
Race | | | | | |
White | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) |
African American | 0.52 (0.38 to 0.71)†† | 0.49 (0.35 to 0.67)†† | 0.51 (0.37 to 0.70)†† | 0.53 (0.38 to 0.72)†† | 0.54 (0.39 to 0.75)†† |
Other non-white | 0.95 (0.60 to 1.52) | 0.95 (0.59 to 1.52) | 1.10 (0.69 to 1.75) | 0.96 (0.60 to 1.53) | 0.98 (0.60 to 1.58) |
Body mass index | 0.98 (0.96 to 1.00)* | 0.98 (0.96 to 1.00) | 0.98 (0.96 to 1.00)* | 0.98 (0.96 to 1.00) | 0.98 (0.96 to 1.00) |
hsCRP ≥ 3 mg/ml | 2.09 (1.59 to 2.74)†† | 2.02 (1.54 to 2.66)†† | 2.12 (1.61 to 2.80)†† | 2.06 (1.57 to 2.71)†† | 2.07 (1.58 to 2.72)†† |
DAS28 category | | | | | |
<2.6 (remission) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) | 1.00 (Referent) |
2.6 to 3.2 (low activity) | 1.39 (0.92 to 2.11) | 1.38 (0.91 to 2.11) | 1.35 (0.88 to 2.06) | 1.40 (0.92 to 2.13) | 1.40 (0.92 to 2.12) |
3.3 to 5.1 (moderate activity) | 1.50 (1.08 to 2.10)* | 1.55 (1.10 to 2.17)* | 1.46 (1.04 to 2.05)* | 1.54 (1.10 to 2.16)* | 1.55 (1.11 to 2.17)* |
> 5.1 (high activity) | 1.78 (1.22 to 2.59)† | 1.84 (1.25 to 2.70)† | 1.77 (1.21 to 2.59)† | 1.84 (1.26 to 2.69)† | 1.87 (1.28 to 2.75)† |
rs5744455 (CD14/–651) | | | | | |
TT | — | 1.00 (Referent) | — | — | — |
CT or CC | | 0.77 (0.60 to 0.99)* | | | |
rs2569193 (CD14/–2838) | | | | | |
GG | — | — | 1.00 (Referent) | — | — |
AG or AA | | | 1.27 (1.00 to 1.61) | | |
rs2569190 (CD14/–260) | | | | | |
GG | — | — | — | 1.00 (Referent) | — |
AG or AA | | | | 1.04 (0.80 to 1.35) | |
rs2915863 (CD14/–1720) | | | | | |
TT | — | — | — | — | 1.00 (Referent) |
CT or CC | | | | | 1.11 (0.86 to 1.43) |